176 related articles for article (PubMed ID: 18507016)
1. Role of DNA content analysis and immunohistochemistry in the evaluation of the risk of unfavourable outcome in Wilms' tumours.
Osterheld MC; Caron L; Meagher-Villemure K
Anticancer Res; 2008; 28(2A):751-6. PubMed ID: 18507016
[TBL] [Abstract][Full Text] [Related]
2. Male and female breast cancer--differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis.
André S; Pinto AE; Laranjeira C; Quaresma M; Soares J
Pathobiology; 2007; 74(6):323-7. PubMed ID: 18087196
[TBL] [Abstract][Full Text] [Related]
3. Regional DNA content heterogeneity in Wilms' tumor: incidence and potential clinical relevance.
Yildiz I; Jaffe N; Aksoy F; el-Naggar AK
Anticancer Res; 1994; 14(3B):1365-9. PubMed ID: 8067707
[TBL] [Abstract][Full Text] [Related]
4. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome.
Lahoti C; Thorner P; Malkin D; Yeger H
Am J Pathol; 1996 May; 148(5):1577-89. PubMed ID: 8623926
[TBL] [Abstract][Full Text] [Related]
6. p53 expression in Wilms' tumor: a possible role as prognostic factor.
Beniers AJ; Efferth T; Füzesi L; Granzen B; Mertens R; Jakse G
Int J Oncol; 2001 Jan; 18(1):133-9. PubMed ID: 11115550
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical examinations (Ki67, p53, nm23) and DNA cytophotometry in bladder cancer.
Krause FS; Feil G; Bichler KH
Anticancer Res; 2000; 20(6D):5023-8. PubMed ID: 11326661
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of p53 expression in Wilms' tumor in children.
Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P
Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734
[TBL] [Abstract][Full Text] [Related]
9. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.
Liu WG; Gu WZ; Zhou YB; Tang HF; Li MJ; Ma WX
Eur J Clin Invest; 2008 Dec; 38(12):931-8. PubMed ID: 19021718
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of proliferating cell nuclear antigen in Wilms' tumour in children.
Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kantorowicz S; Daszkiewicz P
Eur J Surg Oncol; 2002 Feb; 28(1):67-71. PubMed ID: 11869017
[TBL] [Abstract][Full Text] [Related]
11. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of DNA content in childhood renal tumours.
Kumar S; Marsden HB; Cowan RA; Barnes JM
Br J Cancer; 1989 Feb; 59(2):291-5. PubMed ID: 2539176
[TBL] [Abstract][Full Text] [Related]
13. C-kit protein expression in Wilms' tumour: an immunohistochemical study.
Giordano G; Campanini N; Rocco A; Donofrio V; Bertolini P; Falleti J; Pettinato G
Eur J Surg Oncol; 2009 Jun; 35(6):629-35. PubMed ID: 19010635
[TBL] [Abstract][Full Text] [Related]
14. p57KIP2 immunohistochemistry in early molar pregnancies: emphasis on its complementary role in the differential diagnosis of hydropic abortuses.
Merchant SH; Amin MB; Viswanatha DS; Malhotra RK; Moehlenkamp C; Joste NE
Hum Pathol; 2005 Feb; 36(2):180-6. PubMed ID: 15754295
[TBL] [Abstract][Full Text] [Related]
15. Topoisomerase IIalpha in Wilms' tumour: gene alterations and immunoexpression.
Tretiakova M; Turkyilmaz M; Grushko T; Kocherginsky M; Rubin C; Teh B; Yang XJ
J Clin Pathol; 2006 Dec; 59(12):1272-7. PubMed ID: 16556665
[TBL] [Abstract][Full Text] [Related]
16. DNA quantitation of Wilms' tumour (nephroblastoma) using flow cytometry and image analysis.
Gururangan S; Dorman A; Ball R; Curran B; Leader M; Breatnach F; O'Meara A
J Clin Pathol; 1992 Jun; 45(6):498-501. PubMed ID: 1320635
[TBL] [Abstract][Full Text] [Related]
17. Role of immunocytochemistry, electron microscopy, and DNA analysis in fine-needle aspiration biopsy diagnosis of Wilms' tumor.
Ellison DA; Silverman JF; Strausbauch PH; Wakely PE; Holbrook CT; Joshi VV
Diagn Cytopathol; 1996 Mar; 14(2):101-7. PubMed ID: 8964164
[TBL] [Abstract][Full Text] [Related]
18. [Correlation of cytologic and DNA ploidy evidence and prognosis in childhood Wilm's tumor].
Novik VI; Krasil'nikova LA; Kolygin BA; Punanov IuA
Vopr Onkol; 2004; 50(2):214-8. PubMed ID: 15176226
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical evaluation of the percentage of proliferating neoplastic cells of Wilms' tumor in children by means of the MIB-1 monoclonal antibody].
Juszkiewicz P
Ann Acad Med Stetin; 1997; 43():113-27. PubMed ID: 9471911
[TBL] [Abstract][Full Text] [Related]
20. Feulgen DNA values in Wilms' tumour in relation to prognosis.
Oppedal BR; Glomstein A; Zetterberg A
Pathol Res Pract; 1988 Nov; 183(6):756-60. PubMed ID: 2464818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]